Adagrasib
PubChem 138611145
was used by NIH 3D workflows to automatically generate models for
Antoine Simoneau
Created:
8/12/24
Submitted:
10/9/26
Published:
10/9/26
138611145-bas-color-print_cautionAtoms shown as ball-and-stick (geometry appears faceted on screen; apply smooth normals in Blender or similar to improve visualization; generally smooth when 3D printed) with standard colors. 3D printable, with caution, using certain 3D printers.
Select an image below to view
Learn more about NIH 3D workflow outputs
Category
Description
Adagrasib (MRTX849) is an oral, small-molecule KRAS inhibitor developed by Mirati Therapeutics. KRAS mutations are highly common in cancer and account for approximately 85% of all RAS family mutations.
